Skip to main content
. 2017 Feb 16;17:139. doi: 10.1186/s12885-017-3112-0

Table 2.

Agreement table at the dichotomous level for valid, non-missing results

mCRC samples (n = 182) therascreen KRAS RGQ PCR Kit
Idylla™ KRAS Mutation Test KRAS mutation KRAS Wild-type Totals
KRAS Mutation 79 5 84
KRAS Wild-type 1 97 98
Totals 80 102 182

Overall agreement between therascreen and Idylla™ platform for detection of KRAS mutations. mCRC metastatic colorectal cancer. KRAS Wild type = no mutation detected